查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1627942

2024 - 2032 年冠状动脉绕道移植市场机会、成长动力、产业趋势分析与预测

Coronary Artery Bypass Graft Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球冠状动脉绕道手术市场估值达118亿美元，预计2024年至2032年复合年增长率为7.1%。 ，使用移植物为血液流向心臟创造新的途径。通常，这种移植物来自患者体内的一段血管，例如来自腿部的隐静脉或来自胸部的乳内动脉。

市场将副产品分为移植物、牵开器、心臟定位器、组织稳定器等，移植物进一步细分为隐静脉、胸廓内动脉和其他移植物类型。 2023 年，光是移植部分的价值就超过 31 亿美元。组织工程和 3D 列印等技术进步促进了移植物的生产，生产的产品非常模仿天然血管，增强了相容性，降低了排斥率，并减少了术后併发症。移植物中的创新材料，包括合成材料、生物工程材料和药物洗脱材料，可提高耐用性和生物相容性，减少再狭窄并支持更好的患者康復结果，从而促进市场扩张。

根据方法，冠状动脉绕道手术市场分为传统（体外循环）和微创直接冠状动脉绕道术。传统 CABG 到 2023 年的收入份额为 55.1%，仍然是需要精确控制的复杂、多支血管疾病病例的首选。久坐的生活方式、不良饮食、糖尿病和高血压等因素导致全球 CAD 发病率的上升，导致对 CABG 手术以改善患者预后的需求不断增长。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 118 亿美元
预测值 215 亿美元
复合年增长率 7.1%

美国冠状动脉搭桥术市场在2023 年超过35 亿美元，预计到2032 年将以6.7% 的复合年增长率成长。快的恢復时间和更少的手术时间。美国多血管疾病的流行也导致了冠状动脉绕道手术的需求不断增长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 心血管疾病盛行率增加
      • 科技不断进步
      • 高血压盛行率上升
      • 有利的报销方案
    • 产业陷阱与挑战
      • 与手术相关的高成本
      • 与手术相关的併发症
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 未来市场趋势
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 移植物
    • 大隐静脉移植物
    • 胸廓内动脉移植物
    • 其他移植物
  • 牵开器
  • 心臟定位器
  • 组织稳定剂
  • 其他产品

第 6 章：市场估计与预测：依方法，2021 - 2032

  • 主要趋势
  • 传统（体外循环）CABG
  • 微创直接冠状动脉绕道术
    • 非体外循环冠状动脉绕道术
    • 锁孔冠状动脉绕道手术
    • 其他微创冠状动脉绕道手术

第 7 章：市场估计与预测：按手术类型，2021 - 2032 年

  • 主要趋势
  • 单次冠状动脉绕道手术
  • 双冠状动脉绕道手术
  • 三重冠状动脉绕道手术
  • 四次冠状动脉绕道手术

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 心臟病中心
  • 其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 10 章：公司简介

  • Abbott Laboratories
  • AngioDynamics
  • AtriCure
  • B. Braun Melsungen AG
  • Boston Scientific
  • Cardinal Health
  • CryoLife
  • Edwards Lifesciences
  • Johnson & Johnson
  • LivaNova
  • Medline Industries
  • Medtronic
  • Nipro Corporation
  • Stryker Corporation
  • Terumo Corporation
简介目录
Product Code: 8564

The Global Coronary Artery Bypass Graft Market reached a valuation of USD 11.8 billion in 2023 and is anticipated to grow at a CAGR of 7.1% from 2024 to 2032. Coronary artery bypass graft (CABG) is a surgical solution for coronary artery disease (CAD), creating a new pathway for blood flow to the heart using a graft. Typically, this graft comes from a section of a blood vessel in the patient's body, such as the saphenous vein from the leg or the internal mammary artery from the chest.

The market divides by-products into grafts, retractors, heart positioners, tissue stabilizers, and others, with grafts further segmented into saphenous veins, internal thoracic arteries, and other graft types. In 2023, the grafts segment alone was valued at over USD 3.1 billion. Technological improvements, such as tissue engineering and 3D printing, have advanced graft production, resulting in products that closely mimic natural vessels, enhancing compatibility, lowering rejection rates, and reducing post-operative complications. Innovative materials in grafts, including synthetic, bioengineered, and drug-eluting options, improve durability and biocompatibility, reducing restenosis and supporting better patient recovery outcomes, which, in turn, fosters market expansion.

By method, the coronary artery bypass graft market is segmented into traditional (on-pump) and minimally invasive direct CABG. Traditional CABG, which had a leading revenue share of 55.1% in 2023, remains the preferred choice for complex, multi-vessel disease cases requiring precise control. The rise in CAD globally-driven by factors like sedentary lifestyles, poor diet, diabetes, and hypertension-has led to a growing need for CABG procedures to improve patient outcomes.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$11.8 Billion
Forecast Value$21.5 Billion
CAGR7.1%

U.S. coronary artery bypass graft market exceeded USD 3.5 billion in 2023 and is projected to grow at a CAGR of 6.7% through 2032. U.S. hospitals are adopting advanced surgical techniques, including minimally invasive and robotic-assisted CABG, which offer faster recovery times and fewer post-surgical complications, making the procedure increasingly appealing. The prevalence of multi-vessel disease in the U.S. also contributes to the rising demand for CABG procedures.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing in prevalence of cardiovascular diseases
      • 3.2.1.2 Growing technological advancement
      • 3.2.1.3 Rising prevalence of hypertension
      • 3.2.1.4 Favorable reimbursement scenario
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with surgery procedures
      • 3.2.2.2 Complications associated with the surgery
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Grafts
    • 5.2.1 Saphenous vein grafts
    • 5.2.2 Internal thoracic artery grafts
    • 5.2.3 Other grafts
  • 5.3 Retractors
  • 5.4 Heart positioners
  • 5.5 Tissue stabilizers
  • 5.6 Other products

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Traditional (on-pump) CABG
  • 6.3 Minimally invasive direct CABG
    • 6.3.1 Off-pump CABG
    • 6.3.2 Keyhole CABG
    • 6.3.3 Other minimally invasive CABG surgeries

Chapter 7 Market Estimates and Forecast, By Surgery Type, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Single CABG surgery
  • 7.3 Double CABG surgery
  • 7.4 Triple CABG surgery
  • 7.5 Quadruple CABG surgery

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Cardiology centers
  • 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Abbott Laboratories
  • 10.2 AngioDynamics
  • 10.3 AtriCure
  • 10.4 B. Braun Melsungen AG
  • 10.5 Boston Scientific
  • 10.6 Cardinal Health
  • 10.7 CryoLife
  • 10.8 Edwards Lifesciences
  • 10.9 Johnson & Johnson
  • 10.10 LivaNova
  • 10.11 Medline Industries
  • 10.12 Medtronic
  • 10.13 Nipro Corporation
  • 10.14 Stryker Corporation
  • 10.15 Terumo Corporation